Alberto Díaz-Cáceres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alberto Díaz-Cáceres has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Javier Arenas-Montes
Reina Sofia University Hospital
3 shared publications - Pablo Perez-Martinez
Maimonides Biomedical Research Institute of Cordoba (IMIBIC), 14004 Córdoba, Spain
3 shared publications - Alejandro Serrán-Jiménez
Reina Sofia University Hospital
2 shared publications - Elena Maria Yubero-Serrano
Spanish Scientific Research Council, Instituto de la Grasa-CSIC, 41013, Seville, Spain
2 shared publications - Javier Delgado-Lista
Unidad de Lípidos y Arteriosclerosis, Servicio de Medicina Interna, Hospital Universitario Reina Sofía, IMIBIC, Córdoba, España. Departamento de Ciencias Médicas y Quirúrgicas, Universidad de Córdoba, Córdoba, España. CIBER fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, España; Grupo de trabajo de Nutrición y Estilo de Vida, Sociedad Española de Arteriosclerosis, España
2 shared publications - Juan Francisco Alcalá Díaz
Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, 14004 Cordoba, Spain
2 shared publications
Latest Publications
- Open Access
A Promising Biomarker for Predicting Cardiovascular Risk in Asymptomatic Familial Hypercholesterolemia Patients From The SAFEHEART Study
Background: Familial hypercholesterolemia (FH) is an autosomal dominant disorder associated with a markedly increased risk of premature atherosclerotic cardiovascular disease (ASCVD). Genetic and molecular factors, including microRNAs (miRNAs), may serve as biomarkers to improve disease risk prediction. miRNAs are key regulators of biological processes involved in cardiovascular pathology. This study aimed to identify miRNAs that, combined with clinical variables, enhance ASCVD prediction in asymptomatic FH patients from the SAFEHEART cohort. Methods: A total of 400 subjects diagnosed with FH were included. Coronary calcium score (Agatston score) was measured by computed tomography and stratified into three risk categories (0–99, 100–299, >300). Circulating plasma miRNA levels were quantified using the OpenArray platform. Statistical analyses characterized baseline features and assessed predictive performance using ROC curve analysis. Functional enrichment was explored through the MIENTURNET database. Results: Individuals carrying the null allele for the LDL-R gene showed significantly higher plasma miR-1 levels than those carrying the defective allele (p=0.042). Likewise, subjects with an Agatston score of 0–99 exhibited higher miR-1 levels than those with scores >300 (p=0.025). A predictive model based on clinical variables including age, sex, hypertension, smoking, BMI, LDL burden, and lipoprotein(a) achieved an AUC of 0.846 for ASCVD prediction. Incorporating miR-1 increased the AUC to 0.878, representing a statistically significant improvement (DeLong test, p=0.005). Conclusions: miR-1 emerged as a promising biomarker for ASCVD risk prediction in FH patients. When integrated with conventional clinical variables, miR-1 improved the model’s predictive accuracy. These findings suggest that miR-1 could serve as a useful molecular marker for enhanced cardiovascular risk stratification in asymptomatic individuals with familial hypercholesterolemia.
Open AccessA Promising Biomarker for Predicting Cardiovascular Risk in Asymptomatic Familial Hypercholesterolemia Patients From The SAFEHEART Study
Background: Familial hypercholesterolemia (FH) is an autosomal dominant disorder associated with a markedly increased risk of premature atherosclerotic cardiovascular disease (ASCVD). Genetic and molecular factors, including microRNAs (miRNAs), may serve as biomarkers to improve disease risk prediction. miRNAs are key regulators of biological processes involved in cardiovascular pathology. This study aimed to identify miRNAs that, combined with clinical variables, enhance ASCVD prediction in asymptomatic FH patients from the SAFEHEART cohort. Methods: A total of 400 subjects diagnosed with FH were included. Coronary calcium score (Agatston score) was measured by computed tomography and stratified into three risk categories (0–99, 100–299, >300). Circulating plasma miRNA levels were quantified using the OpenArray platform. Statistical analyses characterized baseline features and assessed predictive performance using ROC curve analysis. Functional enrichment was explored through the MIENTURNET database. Results: Individuals carrying the null allele for the LDL-R gene showed significantly higher plasma miR-1 levels than those carrying the defective allele (p=0.042). Likewise, subjects with an Agatston score of 0–99 exhibited higher miR-1 levels than those with scores >300 (p=0.025). A predictive model based on clinical variables including age, sex, hypertension, smoking, BMI, LDL burden, and lipoprotein(a) achieved an AUC of 0.846 for ASCVD prediction. Incorporating miR-1 increased the AUC to 0.878, representing a statistically significant improvement (DeLong test, p=0.005). Conclusions: miR-1 emerged as a promising biomarker for ASCVD risk prediction in FH patients. When integrated with conventional clinical variables, miR-1 improved the model’s predictive accuracy. These findings suggest that miR-1 could serve as a useful molecular marker for enhanced cardiovascular risk stratification in asymptomatic individuals with familial hypercholesterolemia.
- Open Access
- 13 March 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (6) , e037457
Food Insecurity and Its Cardiovascular Implications in Underresourced Communities
Background: Food insecurity is linked to poorer cardiovascular health (CVH) outcomes, particularly in underresourced communities, where social determinants of health play a critical role. Despite the recognized connections, there remains a lack of empirical evidence delineating the implications of food insecurity on CVH. CVH, a broader concept than cardiovascular disease, encompasses the overall well‐being of the cardiovascular system and is supported by favorable lifestyle choices and physiological metrics. Particularly in underresourced communities, the study of CVH could provide valuable insights for early intervention and targeted public health initiatives. This study aimed to fill this knowledge gap. Methods and Results: We conducted a cross‐sectional analysis of baseline data from the E‐DUCASS (Educational Strategy on a Vulnerable Population to Improve Cardiovascular Health and Food Insecurity) program (NCT05379842), a 24‐month randomized study targeting participants at risk for food insecurity. CVH was assessed using the Life's Essential 8 score. The sample included 451 participants aged 12 to 80 years, stratified by age (30.6% children [aged 12–19 years], 35.9% young adults [aged 20–39 years], and 33.5% adults [aged 40–80 years]) and sex (42.1% men and 57.9% women). The mean CVH score was 65.1 (95% CI, 63.9–66.4), with diet, physical activity, nicotine exposure, and body mass index being the lowest‐scoring metrics. Food insecurity significantly influenced CVH; those participants with severe food insecurity had lower CVH scores than those without (effect size, −2.83 [95% CI, −5.10 to −0.56]; P <0.05). Conclusions: Our findings highlight the negative association between food insecurity and CVH in underresourced Mediterranean communities. These results underscore the need for strategies aimed at reducing cardiovascular risk, potentially through health literacy programs like E‐DUCASS, that focus on improving lifestyle and alleviating food insecurity. Registration: URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT05379842.
- 13 March 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (6) , e037457
Open AccessFood Insecurity and Its Cardiovascular Implications in Underresourced Communities
Background: Food insecurity is linked to poorer cardiovascular health (CVH) outcomes, particularly in underresourced communities, where social determinants of health play a critical role. Despite the recognized connections, there remains a lack of empirical evidence delineating the implications of food insecurity on CVH. CVH, a broader concept than cardiovascular disease, encompasses the overall well‐being of the cardiovascular system and is supported by favorable lifestyle choices and physiological metrics. Particularly in underresourced communities, the study of CVH could provide valuable insights for early intervention and targeted public health initiatives. This study aimed to fill this knowledge gap. Methods and Results: We conducted a cross‐sectional analysis of baseline data from the E‐DUCASS (Educational Strategy on a Vulnerable Population to Improve Cardiovascular Health and Food Insecurity) program (NCT05379842), a 24‐month randomized study targeting participants at risk for food insecurity. CVH was assessed using the Life's Essential 8 score. The sample included 451 participants aged 12 to 80 years, stratified by age (30.6% children [aged 12–19 years], 35.9% young adults [aged 20–39 years], and 33.5% adults [aged 40–80 years]) and sex (42.1% men and 57.9% women). The mean CVH score was 65.1 (95% CI, 63.9–66.4), with diet, physical activity, nicotine exposure, and body mass index being the lowest‐scoring metrics. Food insecurity significantly influenced CVH; those participants with severe food insecurity had lower CVH scores than those without (effect size, −2.83 [95% CI, −5.10 to −0.56]; P <0.05). Conclusions: Our findings highlight the negative association between food insecurity and CVH in underresourced Mediterranean communities. These results underscore the need for strategies aimed at reducing cardiovascular risk, potentially through health literacy programs like E‐DUCASS, that focus on improving lifestyle and alleviating food insecurity. Registration: URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT05379842.
- Open Access
- 19 February 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (4) , 2228
Deep Learning Model Approach to Predict Diabetes Type 2 Based on Clinical, Biochemical, and Gut Microbiota Profiles
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease. Gut microbiota plays a key role in metabolic homeostasis and the development of T2DM and its complications. With the advance of artificial intelligence (AI), it is possible to develop novel models based on machine learning (ML) that can predict the risk of developing certain diseases and facilitate their early diagnosis, or even take preventive measures in advance. This can be the case of T2DM, for example. Our objective was to develop a predictive model of the risk of developing T2DM based on clinical, biochemical, and intestinal microbiota parameters, which estimates the time margin for developing this disease. To this end, a Deep Learning Multilayer Perceptron (MLP) algorithm was developed and trained with data from real patients from a current large population epidemiological study. The data were normalised and augmented to increase their diversity and avoid overfitting. The neural network developed was optimised, and the best hyperparameters were chosen for model building by Bayesian optimisation. We succeeded in getting the model to return a numerical result corresponding to the number of months it will take for a particular individual to develop T2DM with an accuracy of 95.2%.
- 19 February 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (4) , 2228
Open AccessDeep Learning Model Approach to Predict Diabetes Type 2 Based on Clinical, Biochemical, and Gut Microbiota Profiles
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease. Gut microbiota plays a key role in metabolic homeostasis and the development of T2DM and its complications. With the advance of artificial intelligence (AI), it is possible to develop novel models based on machine learning (ML) that can predict the risk of developing certain diseases and facilitate their early diagnosis, or even take preventive measures in advance. This can be the case of T2DM, for example. Our objective was to develop a predictive model of the risk of developing T2DM based on clinical, biochemical, and intestinal microbiota parameters, which estimates the time margin for developing this disease. To this end, a Deep Learning Multilayer Perceptron (MLP) algorithm was developed and trained with data from real patients from a current large population epidemiological study. The data were normalised and augmented to increase their diversity and avoid overfitting. The neural network developed was optimised, and the best hyperparameters were chosen for model building by Bayesian optimisation. We succeeded in getting the model to return a numerical result corresponding to the number of months it will take for a particular individual to develop T2DM with an accuracy of 95.2%.
- Open Access
- 16 March 2022
- Published by Instituto Mexicano del Seguro Social in Spanish Journal of Medicine
- Vol. 2 (1)
Educational strategy to improve cardiovascular health and mitigate food insecurity: Rationale for the E-DUCASS program
- 16 March 2022
- Published by Instituto Mexicano del Seguro Social in Spanish Journal of Medicine
- Vol. 2 (1)
Open AccessEducational strategy to improve cardiovascular health and mitigate food insecurity: Rationale for the E-DUCASS program